Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17480197 | 0.85 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL14093062 | 0.84 | FDPS (0.37) | FDPS | |
| SCHEMBL496881 | 0.82 | FDPS (0.40) | FDPS | |
| SCHEMBL6734117 | 0.80 | GGPS1 (0.43) | FDPS | |
| SCHEMBL6741002 | 0.80 | GGPS1 (0.43) | FDPS | |
| SCHEMBL6024339 | 0.80 | GGPS1 (0.43) | FDPS | |
| SCHEMBL5452230 | 0.80 | GGPS1 (0.43) | FDPS | |
| SCHEMBL13361514 | 0.80 | GGPS1 (0.43) | FDPS | |
| SCHEMBL28730779 | 0.80 | GGPS1 (0.43) | FDPS | |
| SCHEMBL28613244 | 0.78 | ALDH1A1 (0.32) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110997343-A | On-press developable lithographic printing plate precursor, and method for producing lithographic printing plate | 富士胶片株式会社 | 2020-04-10 | — | — | CN | disclosed |
| CN-105102469-A | Crosslinked peptide hydrogels | AGENCY SCIENCE TECH & RES | 2015-11-25 | — | — | CN | disclosed |
| US-7064234-B2 | Enantioselective cation-exchange materials | CHIRAL TECHNOLOGIES EUROPE SAS (FR) | 2006-06-20 | — | — | US | disclosed |
| US-20050131087-A1 | Enantioselective cation-exchange materials | CHIRAL TECHNOLOGIES EUROPE SAS (FR) | 2005-06-16 | — | — | US | disclosed |
| EP-0756633-B1 | METHOD AND KITS FOR PROCESSING MYCOBACTERIA AND MYCOLIC ACID CONTAINING BACTERIA | INTEGRATED RES TECHNOLOGY LLC (US) | 2005-06-08 | — | — | EP | disclosed |
| US-20040097728-A1 | Method for producing anellated tetrahydro-{1h}-triazoles | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-20 | — | — | US | disclosed |
| US-6737544-B1 | HEATING ABOVE MELTING POINT | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-18 | — | — | US | disclosed |
| EP-1393708-A1 | METHOD OF TREATING HAIR | Kao Corporation (JP) | 2004-03-03 | — | — | EP | disclosed |
| US-20040011373-A1 | Method of treating hair | KAO CORPORATION (JP) | 2004-01-22 | — | — | US | disclosed |
| US-6639070-B1 | 4-substituted 1,3,4-oxadiazines; herbicides | BASF AKTIENGESELLSCHAFT (DE) | 2003-10-28 | — | — | US | disclosed |
| WO-1996010561-A1 | 2-AROYLCYCLOHEXANDIONES, PROCESS FOR PREPARING THE SAME AND THEIR USE AS HERBICIDES OR PLANT GROWTH REGULATORS | BASF AKTIENGESELLSCHAFT (DE) | 1996-04-11 | — | — | WO | disclosed |
| EP-0609259-B1 | CYCLOHEXENONE DERIVATES USED AS HERBICIDES | BASF AG (DE) | 1995-11-22 | — | — | EP | disclosed |
| EP-0666254-A1 | 2-Aroylcydohexanediones, process for their preparation and their use as herbicide or as plant growth regulating agent | BASF AKTIENGESELLSCHAFT (DE) | 1995-08-09 | — | — | EP | disclosed |
| EP-0655995-A1 | CYCLOHEXENONOXIME ETHERS, THEIR PREPARATION AND THEIR USE | BASF Aktiengesellschaft (DE) | 1995-06-07 | — | — | EP | disclosed |
| EP-0609259-A1 | CYCLOHEXENONE DERIVATES USED AS HERBICIDES. | BASF AG (DE) | 1994-08-10 | — | — | EP | disclosed |
| WO-1994004489-A1 | CYCLOHEXENONOXIME ETHERS, THEIR PREPARATION AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 1994-03-03 | — | — | WO | disclosed |
| WO-1993008153-A1 | CYCLOHEXENONE DERIVATES USED AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1993-04-29 | — | — | WO | disclosed |
| EP-0537463-A2 | Substituted pyrido(2,3-d)pyrimidines as antidotes | BASF Aktiengesellschaft (DE) | 1993-04-21 | — | — | EP | disclosed |
| EP-0536936-A1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | Sankyo Company Limited (JP) | 1993-04-14 | — | — | EP | disclosed |
| US-4678841-A | TIN OR TITANIUM HALIDE AND ORGANOSULFONIC ACID AS BINARY CATALYST | KURARAY COMPANY, LTD. (JP) | 1987-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040097728-A1 | Method for producing anellated tetrahydro-{1h}-triazoles | CBR1, CBR3, QSOX1 | FDPS 1098/4885ALDH1A1 709/4885LMNA 3553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.